Enfortumab vedotin-ejfv (ADC)
Produktgrößen
1 mg
£1772,00
DHJ41099-1MG
5 mg
£6137,00
DHJ41099-5MG
Über dieses Produkt
- SKU:
- DHJ41099
- Zusätzliche Namen:
- Padcev, ASG-22ME
- translate.label.attr.clone:
- Enfortumab vedotin-ejfv
- Klonalität:
- Monoclonal, Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
- Immunogen:
- LNIR, NECTIN4, PRR4 receptor-related protein 4, Nectin cell adhesion molecule 4, Ig superfamily receptor LNIR, Nectin-4, PVRL4
- Physischer Zustand:
- Liquid
- Reinheit:
- >90% as determined by sec.
- Aufreinigung:
- Ion Exchange
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- AntibodySystem
- Typ:
- Antibody: Recombinant Antibodies